Physician profile

Joel E Retsky

Gastroenterology (Internal Medicine) · Highland Park, IL

NPI 1568420057

$3,436.45

in general payments reported to CMS, 2019-2025

16 companies · $142 in 2025

The $142 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$335.23

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $872.77 2019-2025 Entyvio
Janssen Biotech, INC. $719.65 2019-2025 Tremfya
Abbvie INC. $419.04 2019-2023
Janssen Scientific Affairs, LLC $309.78 2019-2025 Tremfya
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $185.06 2020-2021
Braintree Laboratories, INC. $182.30 2019-2021
Ucb, INC. $179.54 2019
Pfizer INC. $119.45 2021
Romark Laboratories, Lc $107.55 2020
Allergan, INC. $97.24 2019-2020
Exact Sciences Corporation $85.39 2023 Cologuard Collection Kit
Celgene Corporation $55.00 2019
Intercept Pharmaceuticals, INC. $40.84 2019
Ironwood Pharmaceuticals, INC $28.55 2020
Vivus LLC $18.44 2019
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Endo Pharmaceuticals INC. $15.85 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joel E Retsky

$3,436.45

in general payments reported 2019-2025

Years
2019-2025
Top company
Takeda Pharmaceuticals U.S.A., INC.
Context
The $142 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

https://glasscript.com/doctor/116523/joel-e-retsky

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.